Difference between revisions of "Kaczara P"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{EAGLE | |||
|COST=Member | |||
|COST WG4=WG4}} | |||
{{Person | {{Person | ||
|lastname=Kaczara | |lastname=Kaczara | ||
| Line 15: | Line 19: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== MitoEAGLE Inclusiveness Target Countries - Conference Grant == | |||
****: [[MitoEAGLE_Inclusiveness_Target_Countries#Conference_Grant_-_Grand_Period_4|Conference Grant Grand Period 4]] | |||
Latest revision as of 11:54, 22 January 2020
 |
News and Events |  |
 |
Working Groups | Short-Term Scientific Missions | Management Committee | Members |  |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Kaczara P
MitoPedia topics: EAGLE
COST: Member
COST WG4: WG4
| Name | Kaczara Patrycja, PhD |
|---|---|
| Institution | Jagiellonian Centre for Experimental Therapeutics (JCET),
Jagiellonian University, PL |
| Address | Bobrzynskiego 14, 30-348 |
| City | Krakow |
| State/Province | |
| Country | Poland |
| patrycja.kaczara@jcet.eu | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Lukasiak 2016 Eur J Pharmacol | 2016 | Łukasiak A, Skup A, Chlopicki S, Łomnicka M, Kaczara P, Proniewski B, Szewczyk A, Wrzosek A (2016) SERCA, complex I of the respiratory chain and ATP-synthase inhibition are involved in pleiotropic effects of NS1619 on endothelial cells. Eur J Pharmacol 786:137-47. |
Abstracts
| Published | Reference | |
|---|---|---|
| Kaczara 2020 6th EU-Cardioprotection Meeting Riga | 2020 | Kaczara P, Przyborowski K, Sitek B, Kurpinska A, Kus K, Stojak M, Chlopicki S (2020) Carbon monoxide affords anti-platelet effects through the inhibition of oxidative phosphorylation at complex IV and inhibition of glycolysis by NAD+ depletion. 6th EU-Cardioprotection Meeting 2020 Riga LV. |
